Jungraithmayr W
Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Am J Transplant. 2015 Mar;15(3):594-600. doi: 10.1111/ajt.13126.
Mast cells (MCs) were primarily recognized as effector cells of allergy. These cells are acting predominantly at the interface between the host and the external environment, such as skin, gastrointestinal and the respiratory tract. Only recently, MCs have gained increased recognition as cells of functional plasticity with immune-regulatory properties that influence both the innate and the adaptive immune response in inflammatory disorders, cancer and transplantation. Through the secretion of both proinflammatory and antiinflammatory mediators, MCs can either ameliorate or deteriorate the course and outcome in lung transplantation. Recent research from other models recognized the immune-protective activity of MCs including its role as an important source of IL-10 and TGF-β for the modulation of alloreactive T cell responses or assistance in Treg activity. This paper summarizes the current understanding of MCs in lung transplantation and discusses MC-mediated immune-mechanisms by which the outcome of the engrafted organ is modulated.
肥大细胞(MCs)最初被认为是过敏反应的效应细胞。这些细胞主要作用于宿主与外部环境的界面,如皮肤、胃肠道和呼吸道。直到最近,MCs才越来越被视为具有功能可塑性的细胞,具有免疫调节特性,可影响炎症性疾病、癌症和移植中的固有免疫和适应性免疫反应。通过分泌促炎和抗炎介质,MCs可以改善或恶化肺移植的过程和结果。来自其他模型的最新研究认识到MCs的免疫保护活性,包括其作为IL-10和TGF-β的重要来源在调节同种异体反应性T细胞反应或协助调节性T细胞(Treg)活性方面的作用。本文总结了目前对肺移植中MCs的认识,并讨论了MC介导的免疫机制,通过这些机制可调节移植器官的结局。